|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:68–90. 2011. View Article : Google Scholar
|
|
2
|
Roukos DH and Kappas AM: Limitations in
controlling risk for recurrence after curative surgery for advanced
gastric cancer are now well-explained by molecular-based
mechanisms. Ann Surg Oncol. 8:620–621. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Callander NS, Varki N and Rao LV:
Immunohistochemical identification of tissue factor in solid
tumors. Cancer. 70:1194–1201. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Regina S, Rollin J, Bléchet C, Iochmann S,
Reverdiau P and Gruel Y: Tissue factor expression in non-small cell
lung cancer: relationship with vascular endothelial growth factor
expression, microvascular density, and K-ras mutation. J Thorac
Oncol. 3:689–697. 2008. View Article : Google Scholar
|
|
5
|
Aharon A and Brenner B: Microparticles,
thrombosis and cancer. Best Pract Res Clin Haematol. 22:61–69.
2009. View Article : Google Scholar
|
|
6
|
Zwicker JI: Predictive value of tissue
factor bearing microparticles in cancer associated thrombosis.
Thromb Res. 125(Suppl 2): S89–S91. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amarzguioui M, Peng Q, Wiiger MT, et al:
Ex vivo and in vivo delivery of anti-tissue factor short
interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma
cells. Clin Cancer Res. 12:4055–4061. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Wang M, Amarzguioui M, Liu F,
Fodstad Ø and Prydz H: Downregulation of tissue factor by RNA
interference in human melanoma LOX-L cells reduces pulmonary
metastasis in nude mice. Int J Cancer. 112:994–1002. 2004.
View Article : Google Scholar
|
|
9
|
Nitori N, Ino Y, Nakanishi Y, et al:
Prognostic significance of tissue factor in pancreatic ductal
adenocarcinoma. Clin Cancer Res. 11:2531–2539. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamashita H, Kitayama J, Ishikawa M and
Nagawa H: Tissue factor expression is a clinical indicator of
lymphatic metastasis and poor prognosis in gastric cancer with
intestinal phenotype. J Surg Oncol. 95:324–331. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xin H, Zheng YJ and Han ZG: Effect of
tissue factor on intravascular migration of tumor cells. Chinese
Journal of Pathophysiology. 20:960–963. 2004.(In Chinese).
|
|
12
|
Yu YJ, Ma HT, Cao N, Jiao ZY and Li YM:
Tissue factor influence on invasion and metastasis of human gastric
cancer cells line. Chinese Journal of Bases and Clinics in General
Surgery. 19:942–946. 2012.(In Chinese).
|
|
13
|
Yu YJ, Li YM, Hou XD, Guo C, Cao N and
Jiao ZY: Effect of tissue factor on invasion inhibition and
apoptosis inducing effect of oxaliplatin in human gastric cancer
cell. Asian Pac J Cancer Prev. 13:1845–1849. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rickles FR, Shoji M and Abe K: The role of
the hemostatic system in tumor growth, metastasis, and
angiogenesis: tissue factor is a bifunctional molecule capable of
inducing both fibrin deposition and angiogenesis in cancer. Int J
Hematol. 73:145–150. 2001. View Article : Google Scholar
|
|
15
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rickles FR and Falanga A: Molecular basis
for the relationship between thrombosis and cancer. Thromb Res.
102:V215–V224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davila M, Amirkhosravi A, Coll E, et al:
Tissue factor-bearing microparticles derived from tumor cells:
impact on coagulation activation. J Thromb Haemost. 6:1517–1524.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu JL, May L, Lhotak V, et al: Oncogenic
events regulate tissue factor expression in colorectal cancer
cells: implications for tumor progression and angiogenesis. Blood.
105:1734–1741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tesselaar ME, Romijn FP, Van Der Linden
IK, Prins FA, Bertina RM and Osanto S: Microparticle-associated
tissue factor activity: a link between cancer and thrombosis? J
Thromb Haemost. 5:520–527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rao LV and Pendurthi UR: Tissue
factor-factor VIIa signaling. Arterioscler Thromb Vasc Bio1.
25:47–56. 2005.PubMed/NCBI
|
|
21
|
Hjortoe GM, Petersen LC, Albrektsen T, et
al: Tissue factor-factor VIIa-specific up-regulation of IL-8
expression in MDA-MB-231 cells is mediated by PAR-2 and results in
increased cell migration. Blood. 103:3029–3037. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmitt M, Janicke F, Moniwa N,
Chucholowski N, Pache L and Graeff H: Tumor-associated
urokinase-type plasminogen activator: biological and clinical
significance. Biol Chem Hoppe Seyler. 373:611–622. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taniguchi T, Kakkar AK, Tuddenham EG,
Williamson RC and Lemoine NR: Enhanced expression of urokinase
receptor induced through the tissue factor-factor VIIa pathway in
human pancreatic cancer. Cancer Res. 58:4461–4467. 1998.PubMed/NCBI
|
|
24
|
Francis JL, Biggerstaff J and Amirkhosravi
A: Hemostasis and malignancy. Semin Thromb Hemost. 24:93–109. 1998.
View Article : Google Scholar
|
|
25
|
Zucker S, Mirza H, Conner CE, et al:
Vascular endothelial growth factor induces tissue factor and matrix
metalloproteinase production in endothelial cells: conversion of
prothrombin to thrombin results in progelatinase A activation and
cell proliferation. Int J Cancer. 75:780–786. 1998. View Article : Google Scholar
|
|
26
|
Tang H, Fang J, Shu K, et al: Tissue
factor/FVII regulates doxorubicin-induced apoptosis in glioblastoma
via activating PI3K/Akt signaling. The Chinese-German Journal of
Clinical Oncology. 6:487–491. 2007. View Article : Google Scholar
|
|
27
|
Jiang X, Guo YL and Bromberg ME: Formation
of tissue factor-factor VIIa-factor Xa complex prevents apoptosis
in human breast cancer cells. Thromb Haemost. 96:196–201.
2006.PubMed/NCBI
|
